---
title: "Rinvoq (upadacitinib) in rheumatoid arthritis: Indication questions"
description: "Indication questions on Rinvoq (upadacitinib) in rheumatoid arthritis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Eligibility and Drug names. Questions: Who is RINVOQ indicated for in rheumatoid arthritis? What is the generic name of RINVOQ? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/indication"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Rinvoq (upadacitinib) in rheumatoid arthritis: Indication questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Rinvoq](https://www.rinvoqhcp.com/prescribinginfo)

## Eligibility

<a id="rinvoq-ra-indication"></a>

### Who is RINVOQ indicated for in rheumatoid arthritis?

> “RINVOQ is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers.”

Source: [RINVOQ: RINVOQ® (upadacitinib) for Rheumatoid Arthritis, captured 2026-11-08](https://www.rinvoqhcp.com/rheumatoid-arthritis#:~:text=RINVOQ%20is%20indicated%20for%20the,tumor%20necrosis%20factor%20%28TNF%29%20blockers.)

## Drug names

<a id="rinvoq-generic-name"></a>

### What is the generic name of RINVOQ?

> “RINVOQ<sup>®</sup> (upadacitinib) extended-release tablets, for oral use”

Source: [RINVOQ: Prescribing information, page 1, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=1)

## Related pages
- [Medical information: Rinvoq (upadacitinib): Rheumatoid arthritis](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis)
- [Pharmacology](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/access-and-coverage)
